Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
Public ClinicalTrials.gov record NCT01747629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week Comparison of the Efficacy and Safety and Steady-State Pharmacokinetics of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy of Albuterol Spiromax® versus placebo in subjects with persistent asthma.
Study identification
- NCT ID
- NCT01747629
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2012 (Type not available)
- Primary completion
- Oct 2013 (Actual)
- Completion
- Nov 2013 (Actual)
- Last update posted
- Jun 26, 2015
2012 – 2013
United States locations
- U.S. sites
- 35
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 10225 | Costa Mesa | California | — | — |
| Teva Investigational Site 10250 | Encinitas | California | — | — |
| Teva Investigational Site 10230 | Huntington Beach | California | — | — |
| Teva Investigational Site 10255 | Palmdale | California | — | — |
| Teva Investigational Site 10231 | Rancho Mirage | California | — | — |
| Teva Investigational Site 10252 | Riverside | California | — | — |
| Teva Investigational Site 10242 | Rolling Hills Estates | California | — | — |
| Teva Investigational Site 10238 | San Diego | California | — | — |
| Teva Investigational Site 10243 | San Jose | California | — | — |
| Teva Investigational Site 10247 | Miami Lakes | Florida | — | — |
| Teva Investigational Site 10239 | Tallahassee | Florida | — | — |
| Teva Investigational Site 10234 | Tampa | Florida | — | — |
| Teva Investigational Site 10253 | Bangor | Maine | — | — |
| Teva Investigational Site 10257 | Baltimore | Maryland | — | — |
| Teva Investigational Site 10254 | White Marsh | Maryland | — | — |
| Teva Investigational Site 10235 | Fall River | Massachusetts | — | — |
| Teva Investigational Site 10236 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 10226 | Minneapolis | Minnesota | — | — |
| Teva Investigational Site 10233 | Minneapolis | Minnesota | — | — |
| Teva Investigational Site 10241 | St Louis | Missouri | — | — |
| Teva Investigational Site 10229 | Bellevue | Nebraska | — | — |
| Teva Investigational Site 10227 | Rochester | New York | — | — |
| Teva Investigational Site 10244 | Charlotte | North Carolina | — | — |
| Teva Investigational Site 10248 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 10249 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 10232 | Eugene | Oregon | — | — |
| Teva Investigational Site 10259 | Medford | Oregon | — | — |
| Teva Investigational Site 10237 | Portland | Oregon | — | — |
| Teva Investigational Site 10240 | Bethlehem | Pennsylvania | — | — |
| Teva Investigational Site 10246 | Pittsburgh | Pennsylvania | — | — |
| Teva Investigational Site 10256 | Pittsburgh | Pennsylvania | — | — |
| Teva Investigational Site 10251 | Rock Hill | South Carolina | — | — |
| Teva Investigational Site 10228 | Spartanburg | South Carolina | — | — |
| Teva Investigational Site 10258 | San Antonio | Texas | — | — |
| Teva Investigational Site 10245 | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01747629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 26, 2015 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01747629 live on ClinicalTrials.gov.